CEACAM5 and neoplasm: Currently, different serum tumor markers including carcinoembryonic antigen (CEA), cancer antigen 15–3 (CA15‐3), α‐fetoprotein (AFP), and prostate‐specific antigen (PSA) are used in clinical oncology practice.13, 14